1. The Synthetic Compound CC-5079 Is a Potent Inhibitor of Tubulin Polymerization and Tumor Necrosis Factor-α Production with Antitumor Activity
   Ling-Hua Zhang et al, 2006, Cancer Research CrossRef
2. Lx2-32c, a Novel Taxane Derivative, Exerts Anti-resistance Activity by Initiating Intrinsic Apoptosis Pathway in Vitro and Inhibits the Growth of Resistant Tumor in Vivo
   Qing Zhou et al, 2012, Biological and Pharmaceutical Bulletin CrossRef
3. β-Tubulin Mutations Are Associated with Resistance to 2-Methoxyestradiol in MDA-MB-435 Cancer Cells
   Yesim Gökmen-Polar et al, 2005, Cancer Research CrossRef
4. Tubulin-Targeted Drug Action: Functional Significance of Class II and Class IVb β-Tubulin in Vinca Alkaloid Sensitivity
   Pei Pei Gan et al, 2008, Cancer Research CrossRef
5. Stimuli-Responsive Self-Healing Viscoelastic Gels
   Rekha Goswami Shrestha et al, 2017, Stimuli-Responsive Interfaces CrossRef
6. Gene Expression Signature of Acquired Chemoresistance in Neuroblastoma Cells
   Mohamed Jemaà et al, 2020, International Journal of Molecular Sciences CrossRef
7. A Review of the Recent Developments of Molecular Hybrids Targeting Tubulin Polymerization
   Oluwakemi Ebenezer et al, 2022, International Journal of Molecular Sciences CrossRef
8. Neuronal-associated microtubule proteins class III β-tubulin and MAP2c in neuroblastoma: Role in resistance to microtubule-targeted drugs
   Sima Don et al, 2004, Molecular Cancer Therapeutics CrossRef
9. Bcl-2 down-regulation and tubulin subtype composition are involved in resistance of ovarian cancer cells to vinflunine
   Marie-Anne Estève et al, 2006, Molecular Cancer Therapeutics CrossRef
10. Antitumor mechanism of evodiamine, a constituent from Chinese herb Evodiae fructus , in human multiple-drug resistant breast cancer NCI/ADR-RES cells in vitro and in vivo
    Cho-Hwa Liao et al, 2005, Carcinogenesis CrossRef
11. Overexpression of Kinesins Mediates Docetaxel Resistance in Breast Cancer Cells
    Sarmishtha De et al, 2009, Cancer Research CrossRef
12. Natural Products as Cytotoxic Agents
    Mallory Pullman et al, 2021, Burger's Medicinal Chemistry and Drug Discovery CrossRef
13. Resistance to the Tubulin-Binding Agents in Renal Cell Carcinoma: No Mutations in the Class I β-Tubulin Gene but Changes in Tubulin Isotype Protein Expression
    Roisean E. Ferguson et al, 2005, Clinical Cancer Research CrossRef
14. The Synergistic Combination of the Farnesyl Transferase Inhibitor Lonafarnib and Paclitaxel Enhances Tubulin Acetylation and Requires a Functional Tubulin Deacetylase
    Adam I. Marcus et al, 2005, Cancer Research CrossRef
15. Quantification and Analysis of Combination Drug Synergy in High-Throughput Transcriptome Studies
    Zeynep H. Gümüs et al, 2010, 2010 IEEE International Conference on BioInformatics and BioEngineering CrossRef
16. Regulation of Tubulin Gene Expression: From Isotype Identity to Functional Specialization
    Ivana Gasic, 2022, Frontiers in Cell and Developmental Biology CrossRef
17. Heterocyclic Compounds: Importance in Anticancer Drug Discovery
    Naresh Kumar et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef
18. A Compressive Review about Taxol®: History and Future Challenges
    Julia Gallego-Jara et al, 2020, Molecules CrossRef
19. Overexpression of Class III β-Tubulin Predicts Good Response to Taxane-Based Chemotherapy in Ovarian Clear Cell Adenocarcinoma
    Daisuke Aoki et al, 2009, Clinical Cancer Research CrossRef